Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Summary
This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.
Official title: A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
1151
Start Date
2004-09-01
Completion Date
2006-12-01
Last Updated
2026-07-13
Healthy Volunteers
No
Conditions
Interventions
Antidepressant + Placebo
Antidepressant Caps/Tablets Placebo Tablets, Oral, 2-20 mg Placebo, once daily, 6 weeks following an 8 week Prospective Treatment (Baseline) Phase.
Antidepressant + Aripiprazole
Antidepressant Caps/Tablets Aripiprazole Tablets, Oral, 2-20 mg Aripiprazole, once daily, 6 weeks following an 8 week Prospective Treatment (Baseline) Phase.
Locations (28)
Local Institution
Beverly Hills, California, United States
Local Institution
Burbank, California, United States
Local Institution
National City, California, United States
Local Institution
Orange, California, United States
Local Institution
Pasadena, California, United States
Local Institution
Denver, Colorado, United States
Local Institution
Farmington, Connecticut, United States
Local Institution
Jacksonville, Florida, United States
Local Institution
Orlando, Florida, United States
Local Institution
Atlanta, Georgia, United States
Local Institution
Rockville, Maryland, United States
Local Institution
Albuquerque, New Mexico, United States
Local Institution
Brooklyn, New York, United States
Local Institution
New York, New York, United States
Local Institution
Cincinnati, Ohio, United States
Local Institution
Toledo, Ohio, United States
Local Institution
Portland, Oregon, United States
Local Institution
Pittsburgh, Pennsylvania, United States
Local Institution
Memphis, Tennessee, United States
Local Institution
Dallas, Texas, United States
Local Institution
Houston, Texas, United States
Local Institution
Arlington, Virginia, United States
Local Institution
Herndon, Virginia, United States
Local Institution
Richmond, Virginia, United States
Local Institution
Bellevue, Washington, United States
Local Institution
Seattle, Washington, United States
Local Institution
Brown Deer, Wisconsin, United States
Local Institution
Middleton, Wisconsin, United States